Moneycontrol PRO

Endo International

SYMBOL:ENDP|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
7
7
0
0
.
0
0
-0.00 (-3.65%)

As on 18 Mar, 2024 | 05:30 IST

Day Range
0.00
0.00
LH
52 Week Range
0.00
0.08
LH
Open0.00
Previous Close0.00
Beta1.92
High0.00
Low0.00
TTM EPS See historical trend   2.00(-31.74% YoY)
52 Week High0.08
52 Week Low0.00
TTM PE See historical trend    0.00(Low PE)
Mkt. Cap ($ Billion)0.00
Dividend Yield--

Advanced Chart

*Delayed by 20 seconds.

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Very Bearish
Moving AveragesBearish
Technical IndicatorsBearish
Moving Averages CrossoversNeutral

Pivot levels

TypeR1R2R3PPS1S2S3
Classic0.324 0.34 0.350.314 0.30 0.29 0.27
Fibonacci0.324 0.33 0.340.314 0.30 0.30 0.29
Camarilla0.310 0.31 0.320.314 0.31 0.30 0.30

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
50.328
100.344
200.454
500.450
1000.944
2002.35

Returns

Price Performance
1 Week166.67%
1 Month
-42.86%
3 Months100.00%
YTD60.00%
1 Year
-98.93%
3 Years
-99.99%

Financialsin million $

Peers

NamePrice ($)Change%M.Cap(Billion $)TTM PETTM EPSDY52 wk high/lowTechnical Rating
Eli Lilly727.21-2.11691.2745.0216.150.74941.68/623.99-4.78Very Bearish
AbbVie212.56-0.21375.5020.0710.593.49218.58/163.8311.12Very Bullish
Merck84.700.77214.5411.097.644.04120.25/73.352.37Bullish
Pfizer24.881.39140.947.343.397.0730.41/21.052.43Very Bearish
Bristol-Myers Squibb47.080.8495.597.006.730.2563.14/43.010.62Bullish

About the company

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.